Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes.

BACKGROUND

Since its outbreak, Coronavirus disease 2019 (COVID-19), a life-threatening respiratory illness, has rapidly become a public health emergency with a devastating social impact. Lately, the Omicron strain is considered the main variant of concern. Routine blood biomarkers are, indeed, essential for stratifying patients at risk of severe outcomes, and a huge amount of data is available in the literature, mainly for the previous variants. However, only a few studies are available on early routine biochemical blood biomarkers for Omicron-afflicted patients. Thus, the aim and novelty of this study were to identify routine blood biomarkers detected at the emergency room for the early prediction of severe morbidity and/or mortality.

METHODS

449 COVID-19 patients from Sapienza University Hospital of Rome were divided into four groups: (1) the group (patients with mild forms who were quickly discharged); (2) the group (patients that after the admission in the emergency department were hospitalized in a COVID-19 ward); (3) the intensive care unit () group (patients that after the admission in the emergency department required intensive assistance); (4) the group (patients that after the admission in the emergency department had a fatal outcome).

RESULTS

ANOVA and ROC data showed that high-sensitivity troponin-T (TnT), fibrinogen, glycemia, C-reactive protein, lactate dehydrogenase, albumin, D-dimer myoglobin, and ferritin for both men and women may predict lethal outcomes already at the level of the emergency department.

CONCLUSIONS

Compared to previous Delta COVID-19 parallel emergency patterns of prediction, Omicron-induced changes in TnT may be considered other early predictors of severe outcomes.